Focus: Cardinal Health is a $205B revenue healthcare services and pharmaceutical distributor with 10,000+ employees, operating as a critical intermediary in the global pharmaceutical supply chain. The company combines drug distribution, specialty pharmaceuticals, and medical device distribution with an emerging pipeline of diagnostic and therapeutic products.
Profile data last refreshed 37m ago · AI intelligence enriched 3w ago
Hot — 1106 jobs added in 30d
Net +263 (1106 new, 843 removed). Aggressive expansion phase.
Cardinal Health is a strong career choice for supply chain, manufacturing, and commercial professionals seeking stability at scale, but poorly suited for those pursuing innovative drug discovery or biologics development.
Phase 4 procedural device positioned to capture interventional cardiology market.
Help build intelligence for Cardinal Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Cardinal Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Cardinal Health Inc. Stock (US14149Y1082): Declares Quarterly Dividend of $0.5056 Per Share - AD HOC NEWS
Cardinal Health Inc. Stock (US14149Y1082): Declares Quarterly Dividend of $0.5056 Per Share AD HOC NEWS
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder? - 24/7 Wall St.
William Blair Initiates Cardinal Health at Outperform: Is the Pharma Distributor a Stealth Compounder? 24/7 Wall St.
Cardinal Health Pre-Q3 Analysis: Buy, Hold or Sell the Stock Now? - Yahoo Finance
Cardinal Health Pre-Q3 Analysis: Buy, Hold or Sell the Stock Now? Yahoo Finance
Is Cardinal Health Stock Worth Watching Right Now - Kalkine Media
Is Cardinal Health Stock Worth Watching Right Now Kalkine Media
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Here's why you should add Cardinal Health stock to your portfolio now MSN
Cardinal Health Raises Fiscal 2025 Guidance Following Strong First Quarter - HarianBasis.co
Cardinal Health Raises Fiscal 2025 Guidance Following Strong First Quarter HarianBasis.co
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
A novel real-world data methodology for lymphoma outcome classification: the real-world Lugano study.
Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo